<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Bone marrow-derived mesenchymal stem cells (BM-MSC) migrate to <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumours</z:e> and drive <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to identify the molecular mechanisms associated with these heterotypic cellular interactions and analyse their relevance in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Paracrine interactions of BM-MSC with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells were studied using collagen invasion assays, cell counts, flow cytometric cell-cycle analysis and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft models</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The role of neuregulin 1 (NRG1) and the human epidermal growth factor receptor (HER) family pathways were investigated using tyrosine kinase assays, mass spectrometry, pharmacological inhibition, antibody-mediated neutralisation and <z:chebi fb="40" ids="33697">RNA</z:chebi> interference </plain></SENT>
<SENT sid="4" pm="."><plain>Transmembrane neuregulin 1 (tNRG1), HER2 and HER3 expression was analysed in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (n=54), adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal tissues (n=4), <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (n=3) and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> liver tissues (n=3) by immunohistochemistry </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: BM-MSC stimulate invasion, survival and <z:mp ids='MP_0002006'>tumorigenesis</z:mp> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> through the release of soluble NRG1, activating the HER2/HER3-dependent PI3K/AKT signalling cascade in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Similarly, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated mesenchymal cells (T-MC) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> demonstrate high tNRG1 expression, which is significantly associated with advanced Union for International <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Control stage (p=0.005) and invasion depth (p=0.04) and decreased 5-year progression-free survival (p=0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>HER2 and HER3 show membrane localisation in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Paracrine NRG1/HER3 signals initiated by BM-MSC and T-MC promote <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell progression, and high tNRG1 expression is associated with poor prognosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>